Corporate Banner
Satellite Banner
RNAi
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Breakthrough in Cancer Treatment

Published: Friday, November 15, 2013
Last Updated: Friday, November 15, 2013
Bookmark and Share
New technology will soon enable pathologists to automate the process of marking tissue samples with unprecedented accuracy.

TissueMark, developed by PathXL, analyses the detailed structural patterns in tissue samples and marks the boundaries of potentially cancerous sections for more detailed analysis.   The new software will help accelerate cancer research and discovery, reduce time in drug development and to identify new markers of the disease.

To date, this process has been carried out manually, with sections being hand-marked by pathologists on slides.   An expert pathologist can mark around one hundred samples per day. TissueMark can do the same work in greater detail in ten minutes.  

A study in the Journal of the American Medical Association found that adverse drug reactions were the fourth biggest killer in the US, behind heart disease, cancer and strokes.   TissueMark will play a part in the acceleration of the development of personalized medicine and customized drugs.  

Currently an estimated 25 million tissue samples are analysed annually.  Based on these volumes TissueMark has the potential to save pathologists a combined 250,000 working days of effort per annum and complete the same work with pinpoint accuracy in one fiftieth of the time.

TissueMark’s accuracy, combined with huge increases in the speed of processing, opens the gateway to faster and more accurate diagnoses and the development of treatments.  By truncating the diagnostic process and marking slides with a level of precision that cannot be achieved in manual intervention, TissueMark’s developers believe that there is a real prospect of faster drug discovery and better treatment outcomes.  TissueMark analysis can be carried out remotely and cross-border, enabling more effective collaboration between centers of excellence.

Des Speed, chief executive of PathXL, said: “Manual marking is a relatively slow process that can create significant backlogs.  By removing the bottleneck and delivering greater levels of accuracy we can help accelerate drug development, and the detection and analysis of cancerous tissue.”

Dr Scott Binder, Senior Vice Chair and Director of Pathology Clinical Services at the Department of Pathology & Laboratory Medicine at the University of California at Los Angeles (UCLA), said: “I welcome the development of this new TissueMark technology which will bring new levels of efficiency and accuracy to tissue annotation, freeing pathology professionals worldwide to focus their time and expertise on their most important work, the accurate and timely diagnosis of tumors and other disorders.”

Pathology services worldwide are widely acknowledged to be in short supply.  In some countries there are a handful of pathologists to serve the entire population.  One African country, reputedly, has only one fully qualified pathologist to serve the entire population.  By freeing pathologists of responsibility for marking slides, TissueMark enables these experts to apply their expertise to the next and crucial stage of diagnosis, leading to faster and more accurately prescribed treatments. 

The leap in sophistication and accuracy that TissueMark enables has been described by scientists as being the equivalent of the shift from a freehand outline sketch of a country’s border to a high resolution map of the whole country.

PathXL consulted leading molecular pathologists during the development of TissueMark.  All emphasised that for most molecular assays, such as PCR, it is critical to separate tumor from non-tumor tissue to ensure accurate results.  TissueMark is built with this capability.  As the number of molecular tests increase and the options for patients become more intricate, TissueMark’s speed and reliability will become essential.

Dr James Eshleman, Professor of Pathology and Oncology, Associate Director, Molecular Diagnostics Laboratory, Johns Hopkins University School of Medicine, said:  "Tissue annotation for subsequent molecular analysis is very important in modern molecular diagnostic laboratories."

TissueMark’s first release is built to check for the potential presence of lung, colorectal and breast cancers.  Work is near completion on additional software modules to check for the possible presence of several other forms of cancer, including ovarian and prostate cancer.  The software will be compatible with all major scanning technologies.

Des Speed added: “It is now widely accepted that identifying the molecular signature in individual tumours is vital to the development and selection of targeted therapies.  Technologies, such as TissueMark, are now emerging that enable scientists to achieve this.  Equipping pathologists with our technology will lead to faster, better diagnosis and the potential to make significant savings in time and resource at a time when the burden on medical services is rising rapidly.”


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Microscopic Fish are 3D-Printed to do More Than Swim
Researchers demonstrate a novel method to build microscopic robots with complex shapes and functionalities.
Inciting an Immune Attack on Cancer Cells
A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.
Reprogramming Cancer Cells
Researchers on Mayo Clinic’s Florida campus have discovered a way to potentially reprogram cancer cells back to normalcy.
New Strategy for Combating Adenoviruses
Using an animal model they developed, Saint Louis University and Utah State university researchers have identified a strategy that could keep a common group of viruses called adenoviruses from replicating and causing sickness in humans.
Surprising Mechanism Behind Antibiotic-Resistant Bacteria Uncovered
Now, scientists at TSRI have discovered that the important human pathogen Staphylococcus aureus, develops resistance to this drug by “switching on” a previously uncharacterized set of genes.
Fat in the Family?
Study could lead to therapeutics that boost metabolism.
Imaging Software Could Speed Up Breast Cancer Diagnosis
Researchers use high speed optical microscopy of intact breast tissue specimens to analyze breast tissue.
A Metabolic Master Switch Underlying Human Obesity
Researchers find pathway that controls metabolism by prompting fat cells to store or burn fat.
Synthetic DNA Vaccine Against MERS Shows Promise
A novel synthetic DNA vaccine can, for the first time, induce protective immunity against the Middle East Respiratory Syndrome (MERS) coronavirus in animal species.
How Small RNA Helps Form Memories
In a new study, a team of scientists at Scripps Florida has found that a type of genetic material called "microRNA" (miRNA) plays surprisingly different roles in the formation of memory in animal models.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!